Cargando…

Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia

OBJECTIVE: Anamorelin, a novel selective ghrelin receptor agonist, was approved in Japan for the treatment of cachexia in pancreatic cancer (PC), albeit with limited evidence. This study evaluated the efficacy and safety of anamorelin in PC and examined the impact of the extent of weight loss on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeda, Tsuyoshi, Sasaki, Takashi, Okamoto, Takeshi, Ishitsuka, Takahiro, Yamada, Manabu, Nakagawa, Hiroki, Mie, Takafumi, Furukawa, Takaaki, Kasuga, Akiyoshi, Matsuyama, Masato, Ozaka, Masato, Sasahira, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372274/ https://www.ncbi.nlm.nih.gov/pubmed/36418096 http://dx.doi.org/10.2169/internalmedicine.0730-22

Ejemplares similares

Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer
por: Mie, Takafumi, et al.
Publicado: (2023)

Outcomes of Intraductal Placement of Covered Metal Stents for Unresectable Distal Malignant Biliary Obstruction
por: Yamada, Manabu, et al.
Publicado: (2023)

The efficacy and safety of a duckbill‐type anti‐reflux metal stent as the initial metal stent for distal malignant biliary obstruction in unresectable pancreatic cancer
por: Takeda, Tsuyoshi, et al.
Publicado: (2023)

Diagnostic yield of endoscopic ultrasound-guided tissue acquisition for small solid pancreatic lesions
por: Mie, Takafumi, et al.
Publicado: (2020)

Novel risk factors for recurrent biliary obstruction and pancreatitis after metallic stent placement in pancreatic cancer
por: Takeda, Tsuyoshi, et al.
Publicado: (2020)

Diagnostic yield of endoscopic ultrasound-guided tissue acquisition for small solid pancreatic lesions
por: Mie, Takafumi, et al.
Publicado: (2020)

Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using a 20-Gauge Menghini Needle with a Lateral Forward Bevel and a 22-Gauge Franseen Needle: A Single-Center Large Cohort Study
por: Mie, Takafumi, et al.
Publicado: (2021)

Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients
por: Okamoto, Takeshi, et al.
Publicado: (2023)

Ruptured cystic artery pseudoaneurysm after self‐expandable metal stent placement for malignant biliary obstruction
por: Mie, Takafumi, et al.
Publicado: (2023)

Comparison of tube-assisted mapping biopsy with digital single-operator peroral cholangioscopy for preoperative evaluation of biliary tract cancer
por: Takeda, Tsuyoshi, et al.
Publicado: (2022)

Endoscopic Transluminal Stent Placement for Malignant Afferent Loop Obstruction
por: Yonekura, Chinatsu, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on the Management and End-of-life Care of Unresectable Pancreatic Cancer
por: Kasuga, Akiyoshi, et al.
Publicado: (2022)

Multiple Gastric Metastases after Distal Pancreatectomy for Pancreatic Cancer
por: Yamada, Yuto, et al.
Publicado: (2022)

Pancreatic follicular lymphoma: a report of two cases and literature review
por: Okamoto, Takeshi, et al.
Publicado: (2021)

Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer
por: Kasuga, Akiyoshi, et al.
Publicado: (2022)

Removal of Duckbill‐type laser‐cut anti‐reflux metal stents: Clinical evaluation and in vitro study
por: Yamada, Yuto, et al.
Publicado: (2023)

Successful removal of a biliary metal stent using the stent-in-stent-in-stent technique
por: Matsuyama, Masato, et al.
Publicado: (2023)

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
por: Sawada, Masashi, et al.
Publicado: (2020)

Chemotherapy for Biliary Tract Cancer in 2021
por: Sasaki, Takashi, et al.
Publicado: (2021)

Impact of preoperative self‐expandable metal stent on benign hepaticojejunostomy anastomotic stricture after pancreaticoduodenectomy
por: Mie, Takafumi, et al.
Publicado: (2023)

Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia
por: Tsukiyama, Ikuto, et al.
Publicado: (2023)

Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model
por: Hanada, Kako, et al.
Publicado: (2022)

Evidence for partial pharmaceutical reversal of the cancer anorexia–cachexia syndrome: the case of anamorelin
por: Anker, Stefan D, et al.
Publicado: (2015)

Prospective study of EUS-guided tissue acquisition with a 20G core biopsy needle with a forward bevel for solid pancreatic mass
por: Kanata, Ryo, et al.
Publicado: (2021)

Anamorelin hydrochloride in the treatment of cancer anorexia–cachexia syndrome: design, development, and potential place in therapy
por: Graf, Solomon A, et al.
Publicado: (2017)

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis
por: Uesato, Yasunori, et al.
Publicado: (2020)

Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
por: Pietra, Claudio, et al.
Publicado: (2014)

Oncology Update: Anamorelin
por: Prommer, Eric
Publicado: (2017)

Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study
por: Ishioka, Yoshiko, et al.
Publicado: (2023)

Enteral stent placement for malignant afferent loop obstruction by the through-the-scope technique using a short-type single-balloon enteroscope
por: Sasaki, Takashi, et al.
Publicado: (2018)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia
por: Hamauchi, Satoshi, et al.
Publicado: (2019)

A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
por: Oshima, Yuri, et al.
Publicado: (2022)

Blind Spot of Enteral Stenting for Malignant Duodenal Obstruction due to Colon Cancer: A Rare Case of Duodenocolonic Fistula
por: Sasaki, Takashi, et al.
Publicado: (2021)

Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study
por: Takayama, Koichi, et al.
Publicado: (2022)

The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis
por: Taniguchi, Jumpei, et al.
Publicado: (2023)

Endoscopic Double Stenting for the Management of Combined Malignant Biliary and Duodenal Obstruction
por: Takeda, Tsuyoshi, et al.
Publicado: (2021)

Endoscopic ultrasound-guided choledochoduodenostomy using a drill dilator
por: Okamoto, Takeshi, et al.
Publicado: (2023)

Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
por: Takayama, Koichi, et al.
Publicado: (2016)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index
por: Naito, Tateaki, et al.
Publicado: (2022)

Refractory Monomorphic Ventricular Tachycardia Induced by Anamorelin
por: Sakagami, Hiroaki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n3bdakdt7qb7io89v0gqp1fpuv